Cargando…
SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis
The novel coronavirus can cause a severe respiratory disease with impact on the central nervous system, as has been reported by several medical health services. In the COVID-19 pandemic caused by the SARS-CoV-2 neurotrophic virus, neurologists have focused their attention on the early identification...
Autores principales: | Diaz de la Fe, Amado, Peláez Suárez, Alejandro Armando, Fuentes Campos, Marinet, Cabrera Hernández, Maivis Noemí, Goncalves, Carlos-Alberto, Schultz, Stephen, Siniscalco, Dario, Robinson-Agramonte, Maria Angeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167598/ https://www.ncbi.nlm.nih.gov/pubmed/33921878 http://dx.doi.org/10.3390/diseases9020032 |
Ejemplares similares
-
EEG-Derived Functional Connectivity Patterns Associated with Mild Cognitive Impairment in Parkinson’s Disease
por: Peláez Suárez, Alejandro Armando, et al.
Publicado: (2021) -
Impact of SARS-CoV-2 on neuropsychiatric disorders
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2021) -
Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2022) -
COVID-19 and the Nervous System from a Cuban Experience
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2023) -
Neuroinflammation and Neuromodulation in Neurological Diseases
por: Robinson-Agramonte, Maria de los Angeles, et al.
Publicado: (2019)